These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Outcomes and relapse patterns of stage IB grade 2 or 3 endometrial cancer treated with adjuvant vaginal brachytherapy. Hochreiter A; Kelly JR; Young MR; Litkouhi B; Black JD; Stromberger C; Higgins S; Schwartz PE; Damast S Int J Gynecol Cancer; 2020 Jan; 30(1):48-55. PubMed ID: 31722964 [TBL] [Abstract][Full Text] [Related]
10. Pathologic stage I-II endometrial carcinoma in the elderly: radiotherapy indications and outcome. Citron JR; Sutton H; Yamada SD; Mehta N; Mundt AJ Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1432-8. PubMed ID: 15275729 [TBL] [Abstract][Full Text] [Related]
11. Preliminary analysis of RTOG 9708: Adjuvant postoperative radiotherapy combined with cisplatin/paclitaxel chemotherapy after surgery for patients with high-risk endometrial cancer. Greven K; Winter K; Underhill K; Fontenesci J; Cooper J; Burke T; Int J Radiat Oncol Biol Phys; 2004 May; 59(1):168-73. PubMed ID: 15093913 [TBL] [Abstract][Full Text] [Related]
12. Long-term survival in patients with para-aortic lymph node metastasis with systematic retroperitoneal lymphadenectomy followed by adjuvant chemotherapy in endometrial carcinoma. Hiura M; Nogawa T; Matsumoto T; Yokoyama T; Shiroyama Y; Wroblewski J Int J Gynecol Cancer; 2010 Aug; 20(6):1000-5. PubMed ID: 20683408 [TBL] [Abstract][Full Text] [Related]
13. Adjuvant carboplatin, paclitaxel, and vaginal cuff brachytherapy for stage III endometrial cancer: analysis of outcomes and patterns of recurrence based on pathologic characteristics. Young MR; Higgins SA; Ratner E; Yu JB; Mani S; Silasi DA; Azodi M; Rutherford T; Schwartz PE; Damast S Int J Gynecol Cancer; 2015 Mar; 25(3):431-9. PubMed ID: 25621409 [TBL] [Abstract][Full Text] [Related]
14. FIGO stage IIIC endometrial carcinoma with metastases confined to pelvic lymph nodes: analysis of treatment outcomes, prognostic variables, and failure patterns following adjuvant radiation therapy. Nelson G; Randall M; Sutton G; Moore D; Hurteau J; Look K Gynecol Oncol; 1999 Nov; 75(2):211-4. PubMed ID: 10525373 [TBL] [Abstract][Full Text] [Related]
15. Adjuvant radiotherapy in Stage II endometrial carcinoma: Is brachytherapy alone sufficient for local control? Paydar I; DeWees T; Powell M; Mutch DG; Grigsby PW; Schwarz JK Brachytherapy; 2015; 14(4):427-32. PubMed ID: 25911995 [TBL] [Abstract][Full Text] [Related]
16. Adjuvant combined-modality therapy for stage IIIC endometrioid and non-endometrioid endometrial cancer. Chapman BV; Swanick CW; Ning MS; Allen PK; Soliman PT; Westin SN; Pardeshi V; Broaddus RR; Lu KH; Jhingran A; Eifel PJ; Klopp AH Gynecol Oncol; 2019 Jul; 154(1):22-28. PubMed ID: 31109659 [TBL] [Abstract][Full Text] [Related]
17. The Treatment of Pelvic Locoregional Recurrence of Cervical Cancer After Radical Surgery With Intensity-Modulated Radiation Therapy Compared With Conventional Radiotherapy: A Retrospective Study. Yin YJ; Li HQ; Sheng XG; Du XL; Wang C; Lu CH; Pan CX Int J Gynecol Cancer; 2015 Jul; 25(6):1058-65. PubMed ID: 25647254 [TBL] [Abstract][Full Text] [Related]
18. The role of vaginal brachytherapy in the treatment of surgical stage I papillary serous or clear cell endometrial cancer. Barney BM; Petersen IA; Mariani A; Dowdy SC; Bakkum-Gamez JN; Haddock MG Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):109-15. PubMed ID: 22543202 [TBL] [Abstract][Full Text] [Related]
19. Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma. Creutzberg CL; van Putten WL; Koper PC; Lybeert ML; Jobsen JJ; Wárlám-Rodenhuis CC; De Winter KA; Lutgens LC; van den Bergh AC; van de Steen-Banasik E; Beerman H; van Lent M Lancet; 2000 Apr; 355(9213):1404-11. PubMed ID: 10791524 [TBL] [Abstract][Full Text] [Related]
20. Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer. Watari H; Todo Y; Takeda M; Ebina Y; Yamamoto R; Sakuragi N Gynecol Oncol; 2005 Mar; 96(3):651-7. PubMed ID: 15721407 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]